View Older Stories View More Recent Stories

Jul 31, 2015 07:14AM RADA Electronic Industries (RADA) 6.9M Stock Offering Prices at $1.23/Share
Jul 30, 2015 07:26PM RADA Announces Pricing Of Public Offering Of Its Ordinary Shares
Jul 30, 2015 06:08PM EyeGate Pharmaceuticals Announces Pricing of $10,000,000 Public Offering of Common Stock and Warrants
Jul 30, 2015 06:08PM EyeGate Pharmaceuticals Announces Pricing of $10,000,000 Public Offering of Common Stock and Warrants
Jul 29, 2015 04:15PM Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors
Jul 27, 2015 08:47AM Chardan Capital Sees Axovant's (AXON) RVT-101 Only Costing $5M Upfront; 'Sell' Rating Affirmed
Jul 27, 2015 08:31AM Esperion Therapeutics (ESPR) PT Cut to $40 at Chardan Capital Markets
Jul 27, 2015 08:23AM VistaGen Therapeutics (VSTA) Highlighted at Chardan Capital After Allergan Acquires Comp Naurex
Jul 24, 2015 08:45AM IDI, Inc. Announces $10 Million Registered Direct Offering
Jul 23, 2015 09:40AM Chardan Capital Trims PT on Axovant (AXON) to $9.50; News is Good, but 24+ Late-Stage Alzheimer's Drugs in Development
Jul 22, 2015 08:19AM Chardan Capital Markets Starts Applied Genetic Technologies Corp. (AGTC) at Buy
Jul 15, 2015 10:18AM Notable Analyst Rating Changes 7/15: (GES) (CSX) (LNKD) Upgraded; (LLY) (LPLA) (CINF) Downgraded
Jul 15, 2015 08:30AM OncoCyte Announces Appointment of Andy Arno to Board of Directors
Jul 15, 2015 08:01AM Chardan Capital Markets Starts Energous Corp (WATT) at Buy; Apple, LG, Microsoft or Samsung Seen as Tier 1 Customer
Jul 14, 2015 08:00AM MassRoots Closes $1 Million Financing Round
Jul 8, 2015 10:20AM PlacementTracker Publishes First Half 2015 PIPE Market League Tables
Jul 8, 2015 08:19AM Chardan Capital Says Esperion Therapeutics (ESPR) Concerns 'Unanswered' Despite Lifting of FDA Hold
Jul 7, 2015 05:24PM Market Wrap: Horizon Pharma Gets Hostile on Depomed; Tesla Slumps on Downgrade; U.S. Trade Deficit Widens in May
Jul 7, 2015 12:56PM Unusual 11 Mid-Day Movers 7/7: (DEPO) (PBMD) (IPDN) Higher; (ETRM) (STV) (BZUN) Lower
Jul 7, 2015 10:56AM Chardan Capital Markets Announces Hiring of Andy Arno to The Special Equities Group
Jul 7, 2015 10:03AM Chardan Capital Markets Remains Bullish Following Digital Ally (DGLY) Q2 Pre-Release
Jul 7, 2015 09:59AM Digital Ally (DGLY) Prelim. Q2 Results Outpace, But Chardan Capital Remains Skeptical on FY15 Op. Income Outlook
Jul 7, 2015 09:30AM Pre-Open Stock Movers 07/07: (DEPO) (PBMD) (PNK) Higher; (ETRM) (AMD) (SHLM) Lower (more...)
Jul 7, 2015 08:28AM UPDATE: Chardan Upgrades Himax (HIMX) to Buy Ahead of Microsoft's (MSFT) Announcement on Hololens Availability
Jul 7, 2015 08:26AM La Jolla Pharma (LJPC) PT Raised to $60 at Chardan Capital Markets
Jul 2, 2015 12:12PM Streetinsider.com's Hot Lunchtime Reads 7/2: (VRTX) (TWTR) (AMD) (MDCO) (AMBA)
Jul 2, 2015 10:35AM Vislab Adds Computer Vision to Ambarella's (AMBA) Portfolio; Chardan Affirms at 'Neutral'
Jun 30, 2015 04:01PM Viggle Announces the Closing of a $4.2 Million Underwritten Sale of Common Stock to a Single Institutional Investor
Jun 29, 2015 05:34PM Viggle (VGGL) Prices 2.05M Common Stock Offering $2.05/Share
Jun 29, 2015 05:31PM Viggle Announces Pricing of $4.2 Million Underwritten Sale of Common Stock to a Single Institutional Investor
Jun 29, 2015 04:05PM Ritter Pharmaceuticals, Inc. Announces Closing of $20,000,000 Initial Public Offering
Jun 29, 2015 09:02AM Blue Earth (BBLU) Enters 1.67M Common Stock, Warrants Direct Offering
Jun 29, 2015 09:00AM Blue Earth Announces $2 Million Registered Direct Offering
Jun 25, 2015 04:33PM Immune Pharma (IMNP) Announces Date to Commence Bertilimumab Phase II Bullous Pemphigoid Trial
Jun 25, 2015 04:30PM Immune Pharmaceuticals Initiates Phase II Clinical Trials With Bertilimumab In Ulcerative Colitis And Bullous Pemphigoid
Jun 24, 2015 11:21AM Ritter Pharmaceuticals (RTTR) IPO Opens Flat
Jun 24, 2015 09:53AM Ritter Pharmaceuticals, Inc. Announces Pricing of Initial Public Offering
Jun 23, 2015 08:57AM Chardan Capital Markets Upgrades Avalanche Biotechnologies (AAVL) to Neutral
Jun 23, 2015 06:30AM Chardan Capital Starts Signal Genetics (SGNL) at Buy; MyPRS Test Could See Big Demand
Jun 19, 2015 03:35PM Ritter Pharmaceuticals (RTTR) Amends IPO Filing; Plans to Offer 4M Shares and Sees Price of $5/Share
Jun 18, 2015 10:36AM Notable Analyst Rating Changes 6/18: (JNPR) (HOG) (AMC) Upgraded; (RATE) (LUV) (NMBL) Downgraded
Jun 18, 2015 09:34AM Pre-Open Stock Movers 06/18: (LMNS) (DGLY) (BMRN) Higher; (HERO) (RATE) (ORCL) Lower (more...)
Jun 18, 2015 08:39AM Chardan Capital Starts VistaGen Therapeutics (VSTA) at Buy; Positive on AV-101 as Antidepressant Sans Ketamine Side Effects
Jun 18, 2015 08:30AM Chardan Capital Markets Starts Axovant Sciences (AXON) at Sell; RVT-101 Remains Overrated
Jun 18, 2015 08:16AM Chardan Capital Markets Starts Digital Ally (DGLY) at Buy; FirstVu Should be Key Source of Growth
Jun 16, 2015 09:42AM Chardan Capital Trims PT on Profire Energy (PFIE) to $1.80; FY16 Outlook 'Sharply' Lower than Expected
Jun 16, 2015 08:25AM Chardan Capital Markets Downgrades Avalanche Biotechnologies (AAVL) to Sell
Jun 10, 2015 10:06AM Esperion Therapeutics (ESPR) Price Target Lowered to $50 at Chardan
Jun 9, 2015 10:09AM Chardan Capital Markets Upgrades MaxLinear (MXL) to Buy
Jun 3, 2015 03:28PM Chardan Capital Boosts PT on Ambarella (AMBA) to $90; Stock Continues Defying Conventional Wisdom
View More Recent Stories View Older Stories